|
|
||||||||
Departments of Nuclear Medicine and Histopathology, Centre for Clinical Research, St. Bartholomew's Hospital, London, UK
Correspondence: For reprints contact: J. Bomanji, MD, Dept. of Nuclear Medicine, St. Bartholomew's Hospital, West Smithfield, London EC1A 7BE, United Kingdom.
ABSTRACT
Scintigraphy with 123I-radiolabeled metaiodobenzylguanidine (MIBG) was performed successfully in two patients with metastatic carcinoid tumor. The scintigraphic findings show diversity of the tumor deposits in the uptake of [123I]MIBG in the same patient and between patients.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |